A revised biosynthetic pathway for phosphatidylinositol in Mycobacteria

Hiroyuki Morii1, Midori Ogawa, Kazumasa Fukuda

  • 1Department of Chemistry, University of Occupational and Environmental Health, Japan, 1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu, 807-8555, Japan. h-morii@health.uoeh-u.ac.jp

Journal of Biochemistry
|August 28, 2010
PubMed

Insights

Mycobacterial phosphatidylinositol (PI) is synthesized via phosphatidylinositol phosphate (PIP), not directly from inositol. This study identifies PIP synthase as key in mycobacterial PI production.

Area of Science:

  • Biochemistry
  • Microbiology

Background:

  • Phosphatidylinositol (PI) synthesis in mycobacteria was previously thought to involve free inositol and CDP-diacylglycerol.
  • The role of ATP and the low activity of PI synthase in mycobacteria remained unclear.
  • Enzyme activity in mycobacteria is significantly lower than in yeast.

Purpose of the Study:

  • To elucidate the mechanism of phosphatidylinositol (PI) synthesis in mycobacteria.
  • To identify the specific pathway and enzymes involved in mycobacterial PI production.
  • To investigate the role of myo-inositol 1-phosphate in PI synthesis.

Main Methods:

  • Incubation of CDP-diacylglycerol and [(14)C]1L-myo-inositol 1-phosphate with Mycobacterium smegmatis cell wall components.
  • Identification of synthesized lipids using fast atom bombardment-mass spectrometry and thin-layer chromatography.
  • Cloning and expression of the gene encoding PIP synthase from four mycobacterial species in Escherichia coli.

Main Results:

  • Mycobacterial PI is synthesized from CDP-diacylglycerol and myo-inositol 1-phosphate via phosphatidylinositol phosphate (PIP).
  • PI is formed by the dephosphorylation of PIP.
  • The gene encoding PIP synthase was successfully cloned and expressed, confirming its activity.

Conclusions:

  • Mycobacterial PI synthesis proceeds through a PIP intermediate, which is then dephosphorylated.
  • PIP synthase is a key enzyme in mycobacterial PI production.
  • Minor pathways involving PI/inositol exchange or inositol phosphorylation may also contribute to PI metabolism.

Related Concept Videos

Phosphoinositides and PIPs01:42

Phosphoinositides and PIPs

Phosphoinositides are a group of phospholipids containing a glycerol backbone with two fatty acid chains and a phosphate attached to a myoinositol sugar ring. The inositol head group extends into the cytoplasm, where it is modified by adding phosphate groups to form phosphatidylinositol phosphates or PIPs.
Different phosphoinositides are synthesized and recruited on the cytosolic face of the plasma membrane. The localization of specific phosphoinositides concentrated in separate membrane...
Biosynthesis of Lipids01:29

Biosynthesis of Lipids

Microbial membranes exhibit remarkable diversity in lipid composition, reflecting evolutionary adaptations to various environmental conditions. The three domains of life—Bacteria, Archaea, and Eukarya—synthesize membrane lipids through distinct biosynthetic pathways, leading to fundamental structural differences that impact membrane stability, function, and adaptability.Fatty Acid-Based Lipids in Bacteria and EukaryaBacteria and eukaryotes share a common fatty acid biosynthesis pathway, which...
IP3/DAG Signaling Pathway01:11

IP3/DAG Signaling Pathway

Membrane lipids such as phosphatidylinositol (PI) are precursors for several membrane-bound and soluble second messengers. Specific kinases phosphorylate PI and produce phosphorylated inositol phospholipids. One such inositol phospholipids are the  phosphatidylinositol-4,5 bisphosphate [PI(4,5)P2], present in the inner half of the lipid bilayer. Upon ligand binding, GPCR stimulates Gq proteins to turn on phospholipase Cꞵ. Activated phospholipase Cꞵ cleaves PI(4,5)P2 and produces two-second...
Biosynthesis in Bacteria01:24

Biosynthesis in Bacteria

Biosynthesis in bacteria is a fundamental anabolic process that generates essential macromolecules, including proteins, nucleic acids, lipids, and polysaccharides. These macromolecules are critical for cellular growth, replication, and function. The process is tightly regulated and energetically linked to catabolic pathways to ensure optimal resource utilization.Biosynthetic pathways begin with precursor metabolites such as pyruvate, acetyl-CoA, and glucose-6-phosphate derived from glycolysis,...
Production of Pharmaceuticals01:30

Production of Pharmaceuticals

Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under sterile, tightly...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...